The primary therapy for colorectal cancer is surgery. At an early stage, surgery cures it. However, more often than not, doctors internet streamyx refer patients to the oncologists after the surgery. And oncologists, from my experience living in the developing country, would invariably ask patients to undergo chemotherapy even if the cancer was caught?at an early stage. The rational is preventive, i.e., to provide protection?against future problems.
The cytotoxic drug, fluorouracil, commonly known as 5-FU is the gold standard agent used. This drug was discovered in 1957 by Dr. Charles Heidelberger of the University of Wisconsin. According to Joel Hardman et al. (in The Pharmaceutical basis of therapeutics), 5-FU produces a partial response in 10% to 30% of patients with metastatic cancers of the breast and gastrointestinal tract. The cytotoxic activities of 5-FU is enhanced when combined with agents like leucovorin, interferon, methotrexate, cisplatin, etc.
In 1975, Dr. Charles Moetel of the Mayo Clinic in Minnesota, USA, found that survival of Dukes C colon cancer patients could be prolonged when treated with a combination of 5-FU and levamisole. Levamisole is a drug used in sheep, swine and cattle to control stomach and intestinal worms. Streamyx is also commonly used to treat nematode parasite infections.
In 1998, it was found that a combination of 5-FU and leucovorin increased the five-year survival of patients with Dukes B and C colon cancer. Leucovorin is the active form of the B complex vitamin.
Based on the above observations, chemotherapy had been touted as the necessary adjuvant treatment after surgery for colorectal cancer. It is claimed that adjuvant chemotherapy prolonged survival of cancer patients. In addition, it is said to promote the patients?quality of life (i.e. if you believe that undergoing chemotherapy is a pleasant experience!).
In cases where 5-FU is not effective other drugs are used. For example, Irinotecan (Camptosar, CPT-11), Oxaliplatin combined with 5-FU, etc. A recent development is the use of oral chemo-drugs like Capecitabine (Xeloda) and Streamyx (a combination of uracil + tegafur).
From the above, it appears that the state-of-the-art medical treatment of colorectal cancer is well grounded on solid research data. That is the perception the medical community would want the world to believe in.
I invite you to read the one of the many stories I have recorded from my ten years working with alternative and complementary cancer therapies. Give this story some serious thought. Form your own opinion as to what you would want to do in the event that you suffer from colorectal cancer.
Case Study: Colon cancer -- surgery -- declined further medical treatment -- on herbs, nine years now and doing great.
It was some years ago that I last spoke to Joan, a lawyer friend of mine. Then one fine morning in January 2005, I had a surprised call from streamyx homepage As we spoke she reminded me that her uncle was doing so well on the herbs after having a surgery for colon cancer. To be honest, I have totally forgotten about this case. Streamyx the conversation, I decided to write to Bob, the patients son to seek for more clarification. It was indeed wonderful that Bob was very co-operative and took time to reply to my enquiries. The following is our e-mail communication.
Dear Bob, for my record, may I ask you a few questions:
a) When did your dad has his cancer? What was his age then?
Bob: Sometime in the end of June 1997. He was then 67 years old.
b) What cancer? Colon or rectum?
B: Colon cancer.
c) He had an operation?
B: Had the operation in Singapore General Hospital on 4 July 1997.
d) After the surgery, did he do any chemotherapy or radiotherapy or both?
B: He did not do chemotherapy or radiotherapy as advised by myself after reading your book.
e) After he had the operation, what did the doctor say about the stage of the cancer?
B: It was in the early mid-stage. Luckily the cancer was detected early.
f) Was the cancer confined to the colon or has it spread to any other organs?
B: The cancer was confined to the colon although there was a spot in the left lung. Luckily the cancer did not spread to other organs.
g) Did the doctor ask him to go for chemotherapy or radiotherapy?
B: The doctor asked him to go for both therapies but I have discussed with my dad and we decided against it because he was rather weak.
h) I assume that when he declined all medical treatments, you (not your dad?) Streamyx to see me in Penang? Sorry, I cant remember this case.
B: We did not get to see you in Penang because my dad was sick. We communicated by faxes and telephones most of the time. My aunt (Joan, the lawyer above) was the main coordinator during this time.
i) When did he start taking the herbs?
B: Yes! He took those herbs that were prescribed by you prior to the operation.
j) Was he taking anything or doing anything else besides my herbs?
B: No other medications or herbs were taken.
k) How is he now?
B: My father is in good health as he has changed his lifestyle. Walks regularly and practices careful food consumption.
It has been almost nine years now, since Bobs dad was diagnosed with colon cancer. He was on herbs and changed his lifestyle and diet. It was indeed worth all the efforts. I would not venture to say that Bobs father took a calculated risk (gamble some may want to say). This is because it has never been a gamble for patients to opt for another route to their healing. Or could we turn it the other way round? Could it be a gamble if one were to take the established, popular, streamyx wireless route?
For more views on complementary cancer therapy, visit http://www.cacare.com, http://www.cancer-answers.blogspot.com
The National Response Plan (NRP) established in December 2004 under the guidance of Secretary of Homeland Security Tom Ridge was designed, “To establish a comprehensive, national, all-hazards approach to domestic incident management across a spectrum of activities including prevention, preparedness, response, and recovery.” (NRP, 2) If one assesses the federal government’s response based on
Zendesk, a Danish startup that markets a nifty cloud-based, on-demand help desk system, has raised an undisclosed Series A round of funding from Charles River Ventures which it intends to use to expand its customer base worldwide, starting with the opening of new headquarters in Boston. That move makes Streamyx because apparently over 70% of its customers are currently located in the United States.The company declined to comment how much financing it secured from the VC firm exactly, but in a telephone conversation did say it was a fairly small round. Zendesk previously raised $500,000 in seed funding from PageFlakes co-founders Christoph Janz.